Recursion Pharmaceuticals (RXRX) Stock Chart & Stock Price History $4.94 +0.16 (+3.35%) Closing price 04:00 PM EasternExtended Trading$4.97 +0.03 (+0.71%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recursion Pharmaceuticals Stock Price Performance The Recursion Pharmaceuticals (RXRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 32.79%, with a year-to-date return of -26.92%. In the past month, the stock has decreased 24.46%, reflecting recent market activity. As of the latest close, Recursion Pharmaceuticals traded at $4.78 with a market cap of $2.08 billion and volume of 14.51 million shares. Receive RXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-14.38%1 Month Performance-24.46%3 Month Performance+19.32%Year-To-Date Performance-26.92%1 Year Performance-32.79% RXRX Stock Chart for Friday, August, 22, 2025 RXRX Chart by TradingView Recursion Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$4.77$4.78+0.21%$4.89$4.7214.51 million shs$2.08 billion08/20/2025$5.09$4.77-6.29%$5.09$4.7324.77 million shs$2.07 billion08/19/2025$5.52$5.09-7.79%$5.54$5.0920.01 million shs$2.21 billion08/18/2025$5.77$5.52-4.33%$5.74$5.4516.99 million shs$2.40 billion08/15/2025$5.64$5.77+2.30%$5.84$5.5214.82 million shs$2.35 billion08/14/2025$5.70$5.64-1.05%$5.69$5.4115.50 million shs$2.29 billion08/13/2025$5.41$5.70+5.36%$5.82$5.5223.45 million shs$2.32 billion08/12/2025$5.29$5.41+2.27%$5.50$5.2916.52 million shs$2.20 billion08/11/2025$5.36$5.29-1.31%$5.54$5.2018.54 million shs$2.15 billion08/08/2025$5.41$5.36-0.92%$5.58$5.3511.99 million shs$2.18 billion Get the Latest News and Ratings for RXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$5.48$5.41-1.28%$5.69$5.4014.21 million shs$2.20 billion08/06/2025$5.53$5.48-0.90%$5.49$5.2817.96 million shs$2.23 billion08/05/2025$5.80$5.53-4.66%$5.96$5.4135.49 million shs$2.25 billion08/04/2025$5.68$5.80+2.11%$5.92$5.6618.25 million shs$2.36 billion08/01/2025$5.95$5.68-4.54%$5.82$5.5817.93 million shs$2.31 billion07/31/2025$5.81$5.95+2.41%$6.09$5.7921.86 million shs$2.42 billion07/30/2025$5.95$5.81-2.35%$6.20$5.7020.28 million shs$2.36 billion07/29/2025$6.31$5.95-5.71%$6.28$5.8623.76 million shs$2.42 billion07/28/2025$6.49$6.31-2.77%$6.69$6.2024.90 million shs$2.56 billion07/25/2025$6.26$6.49+3.67%$6.50$5.9323.55 million shs$2.64 billion07/24/2025$6.43$6.26-2.64%$6.56$6.2522.73 million shs$2.54 billion07/23/2025$6.54$6.43-1.68%$7.14$6.2841.72 million shs$2.61 billion07/22/2025$6.40$6.54+2.19%$6.56$6.0937.13 million shs$2.66 billion07/21/2025$5.84$6.40+9.59%$7.15$6.0374.98 million shs$2.60 billion Related Companies BridgeBio Pharma Stock Chart Verona Pharma PLC American Depositary Share Stock Chart Elanco Animal Health Stock Chart Blueprint Medicines Stock Chart Roivant Sciences Stock Chart Grifols Stock Chart Legend Biotech Stock Chart Revolution Medicines Stock Chart Rhythm Pharmaceuticals Stock Chart Avidity Biosciences Stock Chart Receive RXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RXRX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access